GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Open accessThe DOI matches its Crossref record; 213 of the 216 references it cites were found in a registry or an index.
Abstract
The intestine represents the body’s largest interface between internal organs and external environments except for its nutrient and fluid absorption functions. It has the ability to sense numerous endogenous and exogenous signals from both apical and basolateral surfaces and respond through endocrine and neuronal signaling to maintain metabolic homeostasis and energy expenditure. The intestine also harbours the largest population of microbes that interact with the host to maintain human health and diseases. Furthermore, the gut is known as the largest endocrine gland, secreting over 100 peptides and other molecules that act as signaling molecules to regulate human nutrition and physiology. Among these gut-derived hormones, glucagon-like peptide 1 (GLP-1) and -2 have received the most attention due to their critical role in intestinal function and food absorption as well as their application as key drug targets. In this review, we highlight the current state of the literature that has brought into light the importance of GLP-1 and GLP-2 in orchestrating intestine–microbiota–immune system crosstalk to maintain intestinal barrier integrity, inflammation, and metabolic homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-κB pathway, reducing the release of pro-inflammatory cytokines such as TNF-α and IL-6, and thus suppressing inflammatory pathways.307,413”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“3 million gut microbial genes that constitute the microbiome [81,82].”
BackgroundJaneway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 3×
“It has been reported that GLP-1 mediates several beneficial effects on metabolism including maintaining glucose homeostasis by inducing insulin secretion in response to glucose stimulation [1,2], inhibiting glucagon secretion [9] and expanding pancreatic β cell mass [7,42].”
BackgroundIntroduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Short-chain fatty acids in control of body weight and insulin sensitivity
Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., et al. (2012) · Science · doi:10.1126/science.1219328 · Cited by 1,661
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
Homeostatic Immunity and the Microbiota
Belkaid, Y., & Harrison, O. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.008 · Cited by 1,261
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
Bevins, C. L., & Salzman, N. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2546 · Cited by 1,238
Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Minireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
Schulthess, J., Pandey, S., Capitani, M., Rue-Albrecht, K. C., Arnold, I., Franchini, F., Chomka, A., Ilott, N. E., Johnston, D. G. W., Pires, E., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.018 · Cited by 1,037
The gut microbiome: Relationships with disease and opportunities for therapy
Durack, J., & Lynch, S. V. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 943
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0164-x · Cited by 894
Psichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., Ghatei, M. A., Bloom, S. R., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.153 · Cited by 886
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Bansal, T., Alaniz, R. C., Wood, T. K., & Jayaraman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906112107 · Cited by 868
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses
Hapfelmeier, S., Lawson, M. A. E., Slack, E., Kirundi, J. K., Stoel, M., Heikenwalder, M., Cahenzli, J., Velykoredko, Y., Balmer, M. L., Endt, K., et al. (2010) · Science · doi:10.1126/science.1188454 · Cited by 835
IgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis
Peterson, D. A., McNulty, N. P., Guruge, J. L., & Gordon, J. I. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.013 · Cited by 828
Microbiota and Host Nutrition across Plant and Animal Kingdoms
Hacquard, S., Garrido-Oter, R., González, A., Spaepen, S., Ackermann, G., Lebeis, S., McHardy, A. C., Dangl, J. L., Knight, R., Ley, R., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.009 · Cited by 779
Walker, A. W., Sanderson, J. D., Churcher, C., Parkes, G. C., Hudspith, B. N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 726
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916038 · Cited by 723
Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
Intestinal Microbial Diversity during Early-Life Colonization Shapes Long-Term IgE Levels
Cahenzli, J., Köller, Y., Wyss, M., Geuking, M. B., & McCoy, K. D. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.10.004 · Cited by 611
Abbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R. C., Ghatei, M. A., & Bloom, S. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.011 · Cited by 599
Epithelial crosstalk at the microbiota–mucosal interface
Wells, J. M., Rossi, O., Meijerink, M., & van Baarlen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000092107 · Cited by 579
Gasaly, N., de Vos, P., & Hermoso, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658354 · Cited by 578
Carvalho, F. A., Koren, O., Goodrich, J. K., Johansson, M. E. V., Nalbantoglu, I., Aitken, J. D., Su, Y., Chassaing, B., Walters, W. A., González, A., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.004 · Cited by 548
Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells
Chimerel, C., Emery, E., Summers, D. K., Keyser, U., Gribble, F. M., & Reimann, F. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.032 · Cited by 548
Arakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., & Watada, H. (2010) · Diabetes · doi:10.2337/db09-1694 · Cited by 548
Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472 · cited 1×
“Given that enterocytes are the site for CM synthesis and secretion but do not express GLP-1R [3,54], the effect of GLP 1R agonist on modulation of CM secretion and apoB48 levels is likely the result of indirect mechanisms.”
BackgroundDysregulation of Allergic Airway Inflammation in the Absence of Microbial Colonization
Herbst, T., Sichelstiel, A., Schär, C., Yadava, K., Bürki, K., Cahenzli, J., McCoy, K., Marsland, B. J., & Harris, N. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1574oc · Cited by 440
Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2
Furuta, M., Yano, H., Zhou, A., Rouillé, Y., Holst, J. J., Carroll, R., Ravazzola, M., Orci, L., Furuta, H., & Steiner, D. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6646 · Cited by 431
Tan, T. G., Sefik, E., Geva-Zatorsky, N., Kua, L., Naskar, D., Teng, F., Pasman, L., Ortiz-Lopez, A., Jupp, R., Wu, H.-J. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617460113 · Cited by 427
Microbiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
Discovery, characterization, and clinical development of the glucagon-like peptides
Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418 · cited 4×
“It has been reported that GLP-1 mediates several beneficial effects on metabolism including maintaining glucose homeostasis by inducing insulin secretion in response to glucose stimulation [1,2], inhibiting glucagon secretion [9] and expanding pancreatic β cell mass [7,42].”
BackgroundInfluentialChristiansen, C. B., Gabe, M. B. N., Svendsen, B., Dragsted, L. O., Rosenkilde, M. M., & Holst, J. J. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2017 · Cited by 401
Terminology: nomenclature of mucosa-associated lymphoid tissue
Brandtzaeg, P., Kiyono, H., Pabst, R., & Russell, M. W. (2008) · Mucosal Immunology · doi:10.1038/mi.2007.9 · Cited by 394
Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
Wichmann, A., Allahyar, A., Greiner, T. U., Plovier, H., Lundén, G. Ö., Larsson, T., Drucker, D. J., Delzenne, N. M., Cani, P. D., & Bäckhed, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.012 · Cited by 380
Wu, K., Yuan, Y., Yu, H., Dai, X., Wang, S., Sun, Z., Wang, F., Fei, H., Lin, Q., Jiang, H., et al. (2020) · Blood · doi:10.1182/blood.2019003990 · Cited by 345
Microbiomes as sources of emergent host phenotypes
Lynch, J. B., & Hsiao, E. Y. (2019) · Science · doi:10.1126/science.aay0240 · Cited by 339
Matikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336
Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2
Munroe, D. G., Gupta, A. K., Kooshesh, F., Vyas, T. B., Rizkalla, G., Wang, H., Demchyshyn, L., Yang, Z.-J., Kamboj, R. K., Chen, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1569 · Cited by 328
Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases
Jiao, Y., Wu, L., Huntington, N. D., & Zhang, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00282 · Cited by 321
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice
Tsai, C. H., Hill, M., Asa, S. L., Brubaker, P. L., & Drucker, D. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e77 · Cited by 319
Lee, Y.-S., Park, M.-S., Choung, J.-S., Kim, S.-S., Oh, H.-H., Choi, C.-S., Ha, S.-Y., Kang, Y., Kim, Y., & Jun, H.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2592-3 · Cited by 319
Usami, M., Kishimoto, K., Ohata, A., Miyoshi, M., Aoyama, M., Fueda, Y., & Kotani, J. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.02.012 · Cited by 307
Talsania, T., Anini, Y., Siu, S., Drucker, D. J., & Brubaker, P. L. (2005) · Endocrinology · doi:10.1210/en.2005-0473 · Cited by 306
The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes
Jacobson, A., Yang, D., Vella, M., & Chiu, I. M. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00368-1 · Cited by 305
Exenatide Exerts a Potent Antiinflammatory Effect
Chaudhuri, A., Ghanim, H., Vora, M., Sia, C. L., Korzeniewski, K., Dhindsa, S., Makdissi, A., & Dandona, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1508 · Cited by 284
Yusta, B., Baggio, L. L., Koehler, J., Holland, D., Cao, X., Pinnell, L. J., Johnson-Henry, K. C., Yeung, W., Surette, M. G., Bang, K. W. A., et al. (2015) · Diabetes · doi:10.2337/db14-1577 · Cited by 282 · cited 7×
“Studies have shown that GLP-1 treatment can ameliorate dextran sulfate (DSS)-induced colitis [3,109,127].”
BackgroundInfluentialGrasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J. E., Tercé, F., & Burcelin, R. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.013 · Cited by 281
Hsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., Drucker, D. J., & Adeli, K. (2010) · Diabetologia · doi:10.1007/s00125-009-1611-5 · Cited by 275
Self-citationUmesaki, Y., Setoyama, H., Matsumoto, S., & Okada, Y. (1993) · PubMed Central · Cited by 270
Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
Brooks, L., Viardot, A., Tsakmaki, A., Stolarczyk, E., Howard, J. K., Cani, P. D., Everard, A., Sleeth, M. L., Psichas, A., Anastasovskaj, J., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.10.011 · Cited by 258
The response of the lymphatic tissue to the microbial flora. Studies on germfree mice.
Bauer, H., Horowitz, R. E., Levenson, S. Μ., & Pópper, H. (1963) · PubMed Central · Cited by 257
The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific
Benckert, J., Schmolka, N., Kreschel, C., Zoller, M. J., Sturm, A., Wiedenmann, B., & Wardemann, H. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44447 · Cited by 256
Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 250
Rouillé, Y., Martin, S., & Steiner, D. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26488 · Cited by 245
Hogan, A. E., Gaoatswe, G., Lynch, L., Corrigan, M. A., Woods, C., O’Connell, J., & O’Shea, D. (2014) · Diabetologia · doi:10.1007/s00125-013-3145-0 · Cited by 239
Gastrointestinal Physiology and Function
Greenwood-Van Meerveld, B., Johnson, A. C., & Grundy, D. (2017) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_118 · Cited by 239
Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion
Lebrun, L. J., Lenaerts, K., Kiers, D., Pais de Barros, J.-P., Le Guern, N., Plesnik, J., Thomas, C., Bourgeois, T., Dejong, C. H. C., Kox, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.008 · Cited by 238
Inside the Mucosal Immune System
McGhee, J. R., & Fujihashi, K. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001397 · Cited by 225
Glucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and Chylomicron Production via CD36
Hsieh, J., Longuet, C., Maida, A., Bahrami, J., Xu, E., Baker, C. L., Brubaker, P. L., Drucker, D. J., & Adeli, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.051 · Cited by 216
Self-citationKahles, F., Meyer, C., Möllmann, J., Diebold, S., Findeisen, H. M., Lebherz, C., Trautwein, C., Koch, A., Tacke, F., Marx, N., et al. (2014) · Diabetes · doi:10.2337/db14-0100 · Cited by 212
GLP‐1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells
Egan, J. M., Bulotta, A., Hui, H., & Perfetti, R. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.357 · Cited by 209
Early Development of the Gut Microbiota and Immune Health
Francino, M. (2014) · Pathogens · doi:10.3390/pathogens3030769 · Cited by 207
Wang, S.-Z., Yu, Y.-J., & Adeli, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040527 · Cited by 207
Self-citationSun, L., Pang, Y., Wang, X., Wu, Q., Liu, H., Liu, B., Liu, G., Ye, M., Kong, W., & Jiang, C. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.004 · Cited by 204
Epithelial barrier biology: good fences make good neighbours
Moens, E., & Veldhoen, M. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03506.x · Cited by 200
Bartz, S., Mody, A., Hornik, C., Bain, J., Muehlbauer, M., Kiyimba, T., Kiboneka, E., Stevens, R., Bartlett, J., St Peter, J. V., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4018 · Cited by 198
In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans1
Hartmann, B., Harr, M. B., Jeppesen, P. B., Wojdemann, M., Deacon, C. F., Mortensen, P. B., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6717 · Cited by 191
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
He, S., Kahles, F., Rattik, S., Nairz, M., McAlpine, C. S., Anzai, A., Selgrade, D., Fenn, A. M., Chan, C. T., Mindur, J. E., et al. (2019) · Nature · doi:10.1038/s41586-018-0849-9 · Cited by 167
Wang, L., Li, P., Tang, Z., Yan, X., & Feng, B. (2016) · Scientific Reports · doi:10.1038/srep33251 · Cited by 165
Zhao, L., Chen, Y., Xia, F., Abudukerimu, B., Zhang, W., Guo, Y., Wang, N., & Lu, Y. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00233 · Cited by 165
Xiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.246207 · Cited by 164
Nguyen, A. T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D. J., Lagrost, L., & Grober, J. (2014) · Diabetes · doi:10.2337/db13-0903 · Cited by 161
Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
Tremblay, A. J., Lamarche, B., Deacon, C. F., Weisnagel, S. J., & Couture, P. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01362.x · Cited by 160
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 156
Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
Roed, S. N., Wismann, P., Underwood, C. R., Kulahin, N., Iversen, H., Cappelen, K. A., Schäffer, L., Lehtonen, J., Hecksher-Soerensen, J., Secher, A., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.010 · Cited by 153
Wang, Z.-K., Yang, Y., Chen, Y., Yuan, J. T., Sun, G., & Peng, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14805 · Cited by 150
Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2003 · Cited by 147
Estall, J. L., & Drucker, D. J. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111223 · Cited by 147
Buchman, A. L., Katz, S., Fang, J. C., Bernstein, C. N., & Abou‐Assi, S. G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21117 · Cited by 146
Exenatide Therapy in Obese Patients With Type 2 Diabetes Mellitus Treated with Insulin
Viswanathan, P., Chaudhuri, A., Bhatia, R., Al-Atrash, F., Mohanty, P., & Dandona, P. (2007) · Endocrine Practice · doi:10.4158/ep.13.5.444 · Cited by 142
Glucagon-like peptide-2 increases mesenteric blood flow in humans
Bremholm, L., Hornum, M., Henriksen, B. M., Larsen, S., & Holst, J. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802538195 · Cited by 142
Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function
Brubaker, P. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170055 · Cited by 137
GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production
Hein, G. J., Baker, C., Hsieh, J., Farr, S., & Adeli, K. (2012) · Diabetes · doi:10.2337/db12-0202 · Cited by 135
Self-citationEffects of Antidiabetic Drugs on Gut Microbiota Composition
Montandon, S., & Jornayvaz, F. (2017) · Genes · doi:10.3390/genes8100250 · Cited by 135
GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
Koehler, J. A., Baggio, L. L., Yusta, B., Longuet, C., Rowland, K. J., Cao, X., Holland, D., Brubaker, P. L., & Drucker, D. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.005 · Cited by 133 · cited 2×
“A subsequent study found that gain and loss of GLP-1R signaling regulates mucosal expansion in the small intestine and colon [85].”
BackgroundThe Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals
Ringseis, R., Geßner, D. K., & Eder, K. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083852 · Cited by 133
Inflammation meets metabolic disease: Gut feeling mediated by GLP-1
Zietek, T., & Rath, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00154 · Cited by 131
Worthington, J. J. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150090 · Cited by 126
Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Covașă, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00082 · Cited by 125
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice
Thulesen, J., Hartmann, B., Hare, K. J., Kissow, H., Ørskov, C., Holst, J. J., & Poulsen, S. S. (2004) · Gut · doi:10.1136/gut.2003.035212 · Cited by 124
Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
Cani, P. D., de Hase, E. M., & Hul, M. V. (2021) · Microorganisms · doi:10.3390/microorganisms9061302 · Cited by 124
Madsen, M. S. A., Holm, J. B., Pallejà, A., Wismann, P., Fabricius, K., Rigbolt, K., Mikkelsen, M., Sommer, M., Jelsing, J., Nielsen, H. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52103-x · Cited by 121
Danne, C., Ryzhakov, G., Martínez-López, M., Ilott, N. E., Franchini, F., Cuskin, F., Lowe, E. C., Bullers, S. J., Arthur, J. S. C., & Powrie, F. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.002 · Cited by 120
Steven, S., Jurk, K., Kopp, M., Kröller‐Schön, S., Mikhed, Y., Schwierczek, K., Roohani, S., Kashani, F., Oelze, M. W., Klein, T., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13549 · Cited by 117
Guo, C., Huang, T., Chen, A., Chen, X., Wang, L., Shen, F., & Gu, X. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165826 · Cited by 112
Ehmann, D., Wendler, J., Koeninger, L., Larsen, I. S., Klag, T., Berger, J., Marette, A., Schaller, M., Stange, E. F., Malek, N. P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817376116 · Cited by 112
GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation
Bang-Berthelsen, C. H., Holm, T. L., Pyke, C., Simonsen, L., Søkilde, R., Pociot, F., Heller, R. S., Folkersen, L., Kvist, P. H., Jackerott, M., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000847 · Cited by 111
The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
Ørgaard, A., & Holst, J. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4315-2 · Cited by 111
Tsai, C.-Y., Lu, H.-C., Chou, Y.-H., Liu, P., Chen, H., Huang, M., Lin, C.-H., & Tsai, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.814770 · Cited by 108
Norona, J., Apostolova, P., Schmidt, D., Ihlemann, R., Reischmann, N., Taylor, G., Köhler, N., de Heer, J., Heeg, S., Andrieux, G., et al. (2020) · Blood · doi:10.1182/blood.2020005957 · Cited by 107
Role of inflammation in diabetic cardiomyopathy
Ramesh, P., Yeo, J. L., Brady, E. M., & McCann, G. P. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221083530 · Cited by 106
Kissow, H., Hartmann, B., Holst, J. J., Viby, N., Gasbjerg, L. S., ROSENKILDE, M. M., Hare, K. J., & Poulsen, S. S. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.08.016 · Cited by 105
Mechanisms of Parenteral Nutrition–Associated Liver and Gut Injury
Madnawat, H., Welu, A., Gilbert, E., Taylor, D. B., Jain, S., Manithody, C., Blomenkamp, K., & Jain, A. K. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10461 · Cited by 102
Glucagon-like peptides 1 and 2 in health and disease: A review
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.014 · Cited by 100 · cited 1×
“Both GLP-1 and -2 are co-encoded by proglucagon which is a 180-amino acid precursor with five individually processed domains; glicentin-related pancreatic polypeptide (GRPP), glucagon, intervening peptide—1 and 2 (IP-1/2), GLP-1 and GLP-2 [30] and synthesized in pancreatic α cells, intestinal L-cells and neurons locat…”
BackgroundDrucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 97
Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
Dash, S., Xiao, C., Morgantini, C., Connelly, P. W., Patterson, B. W., & Lewis, G. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.037 · Cited by 97
Gut microbiome differences between metformin‐ and liraglutide‐treated T2 DM subjects
Wang, Z., Saha, S., Horn, S. V., Thomas, E., Traini, C., Sathe, G. M., Rajpal, D. K., & Brown, J. R. (2017) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.9 · Cited by 94
The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis
Han, X., & Kang, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00297 · Cited by 91
Wu, J.-D., Xu, X.-H., Zhu, J., Ding, B., Du, T.-X., Gao, G., Mao, X.-M., Ye, L., Lee, K.-O., & Ma, J.-H. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0048 · Cited by 89
Mitchell, P. D., Salter, B., Oliveria, J. P., El-Gammal, A. I., Tworek, D., Smith, S. G., Sehmi, R., Gauvreau, G. M., Butler, M. W., & O’Byrne, P. M. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12860 · Cited by 85
Bułdak, Ł., Machnik, G., Bułdak, R. J., Łabuzek, K., Bołdys, A., Belowski, D., Basiak, M., & Okopień, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.10.008 · Cited by 84
In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans
Hartmann, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2884 · Cited by 84
Shang, J., Liu, F., Zhang, B., Dong, K., Lu, M., Jiang, R., Xu, Y., Diao, L., Zhao, J., & Tang, H. D. (2021) · PeerJ · doi:10.7717/peerj.11128 · Cited by 82
GLP-1 nanomedicine alleviates gut inflammation
Anbazhagan, A. N., Thaqi, M., Priyamvada, S., Jayawardena, D., Kumar, A., Gujral, T., Chatterjee, I., Mugarza, E., Saksena, S., Onyuksel, H., et al. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.08.004 · Cited by 80
Hsieh, J., Trajcevski, K. E., Farr, S., Baker, C. L., Lake, E. J., Taher, J., Iqbal, J., Hussain, M. M., & Adeli, K. (2015) · Endocrinology · doi:10.1210/en.2015-1110 · Cited by 78
Self-citationXiao, C., Dash, S., Morgantini, C., Patterson, B. W., & Lewis, G. F. (2014) · Diabetes · doi:10.2337/db13-1654 · Cited by 72
Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
Yusta, B., Matthews, D., Koehler, J. A., Pujadas, G., Kaur, K. D., & Drucker, D. J. (2019) · Endocrinology · doi:10.1210/en.2019-00398 · Cited by 72
Advances in Medical Nutrition Therapy: Parenteral Nutrition
Itzhaki, M. H., & Singer, P. (2020) · Nutrients · doi:10.3390/nu12030717 · Cited by 72
Proglucagon-Derived Peptides as Therapeutics
Lafferty, R. A., O’Harte, F. P. M., Irwin, N., Gault, V. A., & Flatt, P. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689678 · Cited by 71
Robinson, E., Cassidy, R. S., Tate, M., Zhao, Y., Lockhart, S., Calderwood, D., Church, R., McGahon, M. K., Brazil, D. P., McDermott, B. J., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0476-7 · Cited by 67
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis
Kissow, H., Hartmann, B., Holst, J. J., & Poulsen, S. S. (2012) · Gut · doi:10.1136/gutjnl-2012-303280 · Cited by 67
Nozu, T., Miyagishi, S., Kumei, S., Nozu, R., Takakusaki, K., & Okumura, T. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13808 · Cited by 67
Panaro, B. L., Yusta, B., Matthews, D., Koehler, J. A., Song, Y., Sandoval, D. A., & Drucker, D. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100990 · Cited by 67 · cited 1×
“The distal intestine is a key location for acute L-cell response and Gcg expression which can influence the levels of GLP-1 in the blood [89].”
BackgroundHorne, R. G., Yu, Y., Zhang, R., Abdalqadir, N., Rossi, L., Surette, M. G., Sherman, P. M., & Adeli, K. (2020) · Nutrients · doi:10.3390/nu12113557 · Cited by 67
Self-citationAsarat, M., Vasiljevic, T., Apostolopoulos, V., & Donkor, O. N. (2015) · Immunological Investigations · doi:10.3109/08820139.2015.1085389 · Cited by 65
Teduglutide: A Review in Short Bowel Syndrome
Kim, E., & Keam, S. J. (2017) · Drugs · doi:10.1007/s40265-017-0703-7 · Cited by 65
Hunt, J. E., Holst, J. J., Jeppesen, P. B., & Kissow, H. (2021) · Biomedicines · doi:10.3390/biomedicines9040383 · Cited by 65
Farr, S., Baker, C., Naples, M., Taher, J., Iqbal, J., Hussain, M., & Adeli, K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304873 · Cited by 61
Self-citationA unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
Sun, W. C., Chen, L.-N., Zhou, Q., Zhao, L., Yang, D., Zhang, H., Cong, Z., Shen, D., Zhao, F., Zhou, F., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00442-0 · Cited by 59
Microbial Control of Intestinal Homeostasis via Enteroendocrine Cell Innate Immune Signaling
Watnick, P. I., & Jugder, B. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.09.005 · Cited by 57
Osinski, C., Gléau, L. L., Poitou, C., de Toro‐Martín, J., Genser, L., Fradet, M., Soula, H. A., Leturque, A., Blugeon, C., Jourdren, L., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00694-1 · Cited by 57
Eliasson, J., Hvistendahl, M., Freund, N., Bolognani, F., Meyer, C., & Jeppesen, P. B. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2223 · Cited by 57
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12748 · Cited by 56
Zatorski, H., Sałaga, M., & Fichna, J. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01698-z · Cited by 56
Mediterranean diet, gut microbiota and health: when age and calories do not add up!
Cani, P. D., & Van Hul, M. (2020) · Gut · doi:10.1136/gutjnl-2020-320781 · Cited by 55
Xie, S., Liu, B., Fu, S., Wang, W., Yin, Y., Li, N., Chen, W., Liu, J., & Liu, D. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363025 · Cited by 54
Grunddal, K. V., Jensen, E. P., Ørskov, C., Andersen, D. B., Windeløv, J. A., Poulsen, S. S., ROSENKILDE, M. M., Knudsen, L. B., Pyke, C., & Holst, J. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab216 · Cited by 53
Lu, V. B., Rievaj, J., O’Flaherty, E. A., Smith, C. A., Pais, R., Pattison, L. A., Tolhurst, G., Leiter, A. B., Bulmer, D. C., Gribble, F. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09045-9 · Cited by 52
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
Gastric emptying and disease activity in inflammatory bowel disease
Keller, J., Binnewies, U., Rösch, M., Juul Holst, J., Beglinger, C., Andresen, V., & Layer, P. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12542 · Cited by 51
Damholt, A. B., Buchan, A. M. J., Holst, J. J., & Kofod, H. (1999) · Endocrinology · doi:10.1210/endo.140.10.7068 · Cited by 47
Gustducin couples fatty acid receptors to GLP-1 release in colon
Li, Y., Kokrashvili, Z., Mosinger, B. J., & Margolskee, R. F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2012 · Cited by 45
Kedees, M. H., Guz, Y., Grigoryan, M., & Teitelman, G. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.022 · Cited by 40
Zheng, Y., Wu, Y., Tao, L., Chen, X., Jones, T. J., Wang, K., & Hu, F. (2020) · Nutrients · doi:10.3390/nu12040959 · Cited by 39
Al-Dwairi, A., Alqudah, T., Al-Shboul, O., Alqudah, M., Mustafa, A., & Alfaqih, M. A. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s152835 · Cited by 37
Glucose and GLP-2 (Glucagon-Like Peptide-2) mobilize intestinal triglyceride by distinct mechanisms
Stahel, P., Xiao, C., Davis, X., Tso, P., & Lewis, G. F. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313011 · Cited by 36
Chang, Y., Deng, Q., Zhang, Z., Zhao, H. Y., Tang, J., Chen, X., Liu, G., Tian, G., Cai, J., & Jia, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30068 · Cited by 36
Feng, Y., Demehri, F. R., Xiao, W., Tsai, Y.-H., Jones, J. C., Brindley, C. D., Threadgill, D. W., Holst, J. J., Hartmann, B., Barrett, T. A., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.12.005 · Cited by 35
Teduglutide in short bowel syndrome patients: A way back to normal life?
Harpain, F., Schlager, L., Hütterer, E., Dawoud, C., Kirchnawy, S., Stift, J., Krotka, P., & Stift, A. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2272 · Cited by 33
Kounatidis, D. C., Vallianou, N. G., Tsilingiris, D., Christodoulatos, G. S., Geladari, E. V., Stratigou, T., Karampela, Ι., & Dalamaga, Μ. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00433-0 · Cited by 33
Drucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1759 · Cited by 32
GLP-1: Broadening the incretin concept to involve gut motility
Hellström, P. M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.004 · Cited by 30
Effect of Roux-en-Y gastric bypass surgery on intestinalAkkermansia muciniphila
Yan, M., Song, M., Bai, R., Cheng, S., & Yan, W. (2016) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v8.i4.301 · Cited by 29
The pivotal relation between glucagon‐like peptides, NFκB and inflammatory bowel disease
Nabeh, O. A., Attallah, M. I., & El‐Gawhary, N. E. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13361 · Cited by 29
The influence of the colon on postprandial glucagon-like peptide 1 (7-36) amide concentration in man
Robertson, M. D., Livesey, G., Morgan, L., Hampton, S., & Mathers, J. C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610025 · Cited by 28
Wang, Y., & Guan, X. (2010) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00585.2009 · Cited by 27
Hansen, N. L., Brønden, A., Nexøe-Larsen, C., Christensen, A. S., Sonne, D. P., Rehfeld, J. F., Albretchsen, N. J. W., Hartmann, B., Vilsbøll, T., Holst, J. J., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000257 · Cited by 24
Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells
Chen, M. E., Naeini, S. M., Srikrishnaraj, A., Drucker, D. J., Fesler, Z., & Brubaker, P. L. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.011 · Cited by 24
Reiner, J., Thiery, J., Held, J., Berlin, P., Skarbaliene, J., Vollmar, B., Jaster, R., Eriksson, P., Lamprecht, G., & Witte, M. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14791 · Cited by 24 · cited 1×
“Interestingly, data from animal models of intestinal barrier dysfunction in mice, rats, and piglets underlines the importance and protective action of GLP-2 in inflammation-mediated intestine injuries [58,134,135].”
BackgroundNeuroprotective Effects of a GLP-2 Analogue in the MPTP Parkinson’s Disease Mouse Model
Zhang, Z., Li, H., Shi, M., Yu, Z., Shao, S., Yuan, Y., Zhang, Z., & Hölscher, C. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202318 · Cited by 22
Nahmias, A., Stahel, P., Tian, L., Xiao, C., & Lewis, G. F. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.121.316311 · Cited by 22
Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
Holst, J. J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.964406 · Cited by 21
Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats
Wu, J., Ren, W., Li, L., Luo, M., Xu, K., Shen, J., Wang, J., Chang, G., Lu, Y., Qi, Y., et al. (2018) · Aging and Disease · doi:10.14336/ad.2017.1001 · Cited by 20
Grande, E. M., Raka, F., HOFFMAN, S. S., & Adeli, K. (2022) · Diabetes · doi:10.2337/db21-1053 · Cited by 20
Self-citation
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“307,413 In terms of apoptosis inhibition, GLP-1 activates the PI3K/Akt signaling pathway, enhances the expression of the anti-apoptotic protein Bcl-2, and inhibits the activation of caspase family proteins, reducing cell apoptosis.”
BackgroundSahoo, D. K., Heilmann, R. M., Paital, B., Patel, A., Yadav, V. K., Wong, D., & Jergens, A. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217165 · Cited by 339
Pillai, S. S., Gagnon, C. A., Foster, C., & Ashraf, A. P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae499 · Cited by 199
The intestine as an endocrine organ and the role of gut hormones in metabolic regulation
Bany Bakar, R., Reimann, F., & Gribble, F. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00830-y · Cited by 144
A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation
Randeni, N., Bordiga, M., & Xu, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179366 · Cited by 127
Metadata
- Authors
- Abdalqadir, N., & Adeli, K.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Adeli, Khosrow
- ORCID
- Adeli, Khosrow
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2022-10-19
- Volume
- 10
- Issue
- 10
- Pages
- 2061
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC9610230
- OpenAlex
- W4306848286
- Cited by
- 119
- References
- 216
- Citations by year
- 2026: 36 · 2025: 38 · 2024: 36 · 2023: 8 · 2022: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institute of Health Research (CIHR) (FDN-148396)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- glucagon-like peptide-1, glucagon-like peptide-2, intestinal barrier integrity, gut microbiota, intestinal immunity, gut-brain-microbiota axis, intestinal inflammation, metabolic homeostasis, gastrointestinal hormones, intestinal endocrine cells, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.